Brief: aTyr Pharma - Atyr Pharma Announces Notice Of Allowance For U.S. Patent For Anti-Neuropilin-2 (Nrp2) Monoclonal Antibodies
29/09/2022 13:27
Sept 29 (Reuters) - aTyr Pharma Inc LIFE.O :
* ATYR PHARMA INC - ATYR PHARMA ANNOUNCES NOTICE OF
ALLOWANCE FOR
U.S. PATENT FOR ANTI-NEUROPILIN-2 (NRP2) MONOCLONAL ANTIBODIES
Source text for Eikon: ID:nGNX75VMRn
Further company coverage: LIFE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on aTyr Pharma
See all newsBrief: Atyr Pharma Announces Research Collaboration With Montefiore Einstein
U.S. STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
US STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
U.S. STOCKS ON THE MOVE-CoreWeave, Versant Media, BlackBerry
aTyr rises as FDA aligns on late-stage lung disease study plan